INDIA – Apollo Indraprastha Hospitals and MediSage have jointly organized a one-of-its-kind meeting held in Delhi focused on cancer management and the latest updates on cancer diagnosis and treatment. The…
Read MoreTag: Cancer
Aga Khan Health Service, Elekta install US$10m radiation therapy equipment in Tanzania
TANZANIA – Aga Khan Health Service Tanzania and Elekta have signed an agreement to purchase and install radiation therapy equipment for the cancer care centre in Dar es Salaam worth…
Read MoreDiscovery launches US$86m Wellth Fund to boost healthcare screenings among its members
SOUTH AFRICA – Discovery Health Medical Scheme has launched a R1.5 billion (US$86.81m) fund to boost healthcare screenings and preventative care among its members amid a spike in severe diagnoses…
Read MoreFDA approves Merck’s Keytruda as adjuvant cancer treatment regardless of tumor’s PD-L1 expression levels
USA — The U.S. Food and Drug Administration (FDA) has cleared Merck & Co.’s immunotherapy Keytruda to treat early cases of lung cancer despite mixed results in the main study…
Read MoreFDA approves Eli Lilly’s drug for advanced mantle cell lymphoma, to retail at US$21,000 per month
USA — The US Food and Drug Administration (FDA) has approved Eli Lilly and Co.’s drug (pirtobrutinib) for the treatment of a rare form of blood cancer. The indication aims…
Read MoreJ&J partners with Evotec on targeted immune-based cancer therapies
USA — Janssen Biotech, Inc., an arm of Johnson & Johnson (J&J), has signed a strategic partnership and license deal with Evotec, a German drug maker to develop first-in-class targeted…
Read MoreCedarcrest Hospital secures grant funding from USTDA for cancer feasibility study
NIGERIA – Cedarcrest Hospitals Limited secured a grant from The U.S. Trade and Development Agency (USTDA) for a feasibility study to develop a comprehensive cancer treatment center in Abuja. The…
Read MoreFDA details approach for finding optimal dosages for new cancer drugs
USA — The US Food and Drug Administration (FDA) has issued a draft guidance to help sponsors identify the optimal dosage for cancer drugs in clinical development and in it,…
Read MoreEveImmune’s oncobiotic drug candidate treats first cancer patient in Phase I clinical trial
FRANCE — EverImmune, a clinical-stage biotech company specializing in the development of live biotherapeutics in microbiota oncology, reports that the first patient has been treated in Phase I clinical trial…
Read MoreAstraZeneca to discontinue Leukemia drug Lumoxiti in the US market
USA— According to a recent Food and Drug Administration (FDA) communication, Lumoxiti for injection will be permanently discontinued in the US market by August 31, 2023. The FDA approved Lumoxiti,…
Read More